Literature DB >> 9635622

Effects on gastric circulation of treatment for portal hypertension in cirrhosis.

S Sezai1, M Ito, Y Sakurai, K Kamisaka, T Abe, F Ikegami, Y Yamamoto, M Hirano.   

Abstract

We evaluated the gastric circulatory effects of the type of treatment administered for portal hypertension. Of 14 patients with cirrhosis, seven received a transjugular intrahepatic portosystemic shunt (TIPS; group T) and seven received percutaneous transhepatic portographic embolization (PTPE; group P). Patients were evaluated over the course of one year. After treatment, portal venous pressure was significantly reduced from 39 +/- 6 cm H2O to 32 +/- 5 (P < 0.001) in group T and was significantly elevated from 29 +/- 10 to 33 +/- 8 (P < 0.05) in group P. The portal flow velocity (Vmean) was significantly higher in group T vs group P (P < 0.0001). The congestion index was significantly lower in group T than in group P (P < 0.0001). The gastric mucosal blood flow was increased in group T but was unchanged in group P. Esophageal varices showed some improvement in both groups, but the portal hypertensive gastropathy was improved only in group T. These findings help to explain the differing effects on the gastric circulation related to the type of treatment used for portal hypertension.

Entities:  

Mesh:

Year:  1998        PMID: 9635622     DOI: 10.1023/a:1018872227652

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Effect of hepatic collateral hemodynamics on gastric mucosal blood flow in patients with liver cirrhosis.

Authors:  Y Yamamoto; S Sezai; S Sakurabayashi; M Hirano; H Oka
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

2.  Portal hypertensive gastropathy in patients with cirrhosis.

Authors:  T Iwao; A Toyonaga; M Sumino; K Takagi; K Oho; M Nishizono; K Ohkubo; R Inoue; E Sasaki; K Tanikawa
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

3.  Case report: percutaneous transhepatic portographic embolization (PTPE) for recurrent hepatic encephalopathy derived from intrahepatic portal-systemic shunts.

Authors:  S Sezai; M Hirano; K Kamisaka
Journal:  Clin Radiol       Date:  1995-11       Impact factor: 2.350

4.  Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.

Authors:  J Quiroga; B Sangro; M Núñez; I Bilbao; J Longo; L García-Villarreal; J M Zozaya; M Betés; J I Herrero; J Prieto
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

5.  Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.

Authors:  K A Somberg; J R Lake; S J Tomlanovich; J M LaBerge; V Feldstein; N M Bass
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

Review 6.  Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis.

Authors:  J L Payen; P Calès; J J Voigt; S Barbe; C Pilette; L Dubuisson; H Desmorat; J P Vinel; A Kervran; J A Chayvialle
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

7.  Reduced gastric mucosal blood flow in patients with portal-hypertensive gastropathy.

Authors:  T Iwao; A Toyonaga; M Ikegami; K Oho; M Sumino; H Harada; M Sakaki; H Shigemori; T Aoki; K Tanikawa
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

8.  Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension.

Authors:  S K Sarin; D V Sreenivas; D Lahoti; A Saraya
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

9.  Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?

Authors:  T T McCormack; J Sims; I Eyre-Brook; H Kennedy; J Goepel; A G Johnson; D R Triger
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

10.  Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy.

Authors:  M Ohta; M Hashizume; H Higashi; K Ueno; M Tomikawa; F Kishihara; H Kawanaka; K Tanoue; K Sugimachi
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

View more
  2 in total

Review 1.  Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

Authors:  K W Burak; S S Lee; P L Beck
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.